Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Adjuvant treatment of colon cancer: past, present and future.

Wils, J.

J Chemother ; 19(2): 115-22, 2007 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-17434818

2.

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

Köhne, C-H; van Cutsem, E; Wils, J; Bokemeyer, C; El-Serafi, M; Lutz, M P; Lorenz, M; Reichardt, P; Rückle-Lanz, H; Frickhofen, N; Fuchs, R; Mergenthaler, H-G; Langenbuch, T; Vanhoefer, U; Rougier, P; Voigtmann, R; Müller, L; Genicot, B; Anak, O; Nordlinger, B.

J Clin Oncol ; 23(22): 4856-65, 2005 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-15939923

3.

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

Wils, J A; Klein, H O; Wagener, D J; Bleiberg, H; Reis, H; Korsten, F; Conroy, T; Fickers, M; Leyvraz, S; Buyse, M.

J Clin Oncol ; 9(5): 827-31, 1991 May.

Artículo en Inglés | MEDLINE | ID: mdl-2016625

4.

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

Coombes, R C; Schein, P S; Chilvers, C E; Wils, J; Beretta, G; Bliss, J M; Rutten, A; Amadori, D; Cortes-Funes, H; Villar-Grimalt, A.

J Clin Oncol ; 8(8): 1362-9, 1990 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-2199622

5.

Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study.

Blijham, G; Wagener, T; Wils, J; de Greve, J; Buset, M; Bleiberg, H; Lacave, A; Dalmark, M; Selleslag, J; Collette, L; Sahmoud, T.

J Clin Oncol ; 14(8): 2266-73, 1996 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-8708716

6.

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.

Vanhoefer, U; Rougier, P; Wilke, H; Ducreux, M P; Lacave, A J; Van Cutsem, E; Planker, M; Santos, J G; Piedbois, P; Paillot, B; Bodenstein, H; Schmoll, H J; Bleiberg, H; Nordlinger, B; Couvreur, M L; Baron, B; Wils, J A.

J Clin Oncol ; 18(14): 2648-57, 2000 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-10894863

7.

Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.

Conroy, T; Etienne, P L; Adenis, A; Wagener, D J; Paillot, B; François, E; Bedenne, L; Jacob, J H; Seitz, J F; Bleiberg, H; Van Pottelsberghe, C; Van Glabbeke, M; Delgado, F M; Merle, S; Wils, J.

J Clin Oncol ; 14(1): 164-70, 1996 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-8558192

8.

Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.

Coombes, R C; Bliss, J M; Wils, J; Morvan, F; Espié, M; Amadori, D; Gambrosier, P; Richards, M; Aapro, M; Villar-Grimalt, A; McArdle, C; Pérez-López, F R; Vassilopoulos, P; Ferreira, E P; Chilvers, C E; Coombes, G; Woods, E M; Marty, M.

J Clin Oncol ; 14(1): 35-45, 1996 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-8558217

9.

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.

Köhne, C-H; Wils, J; Lorenz, M; Schöffski, P; Voigtmann, R; Bokemeyer, C; Lutz, M; Kleeberg, C; Ridwelski, K; Souchon, R; El-Serafi, M; Weiss, U; Burkhard, O; Rückle, H; Lichnitser, M; Langenbuch, T; Scheithauer, W; Baron, B; Couvreur, M L; Schmoll, H J.

J Clin Oncol ; 21(20): 3721-8, 2003 Oct 15.

Artículo en Inglés | MEDLINE | ID: mdl-12963704

10.

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group.

Van Rijswijk, R E N; Jeziorski, K; Wagener, D J Th; Van Laethem, J-L; Reuse, S; Baron, B; Wils, J.

Eur J Cancer ; 40(14): 2077-81, 2004 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-15341982

11.

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.

Hartgrink, H H; van de Velde, C J H; Putter, H; Songun, I; Tesselaar, M E T; Kranenbarg, E Klein; de Vries, J E; Wils, J A; van der Bijl, J; van Krieken, J H J M.

Eur J Surg Oncol ; 30(6): 643-9, 2004 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-15256239

12.

Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and well-tolerated regimen for the treatment of advanced breast cancer.

Wils, J A.

Eur J Cancer ; 29A(15): 2106-8, 1993.

Artículo en Inglés | MEDLINE | ID: mdl-8297648

13.

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

Nitti, D; Wils, J; Sahmoud, T; Curran, D; Couvreur, M L; Lise, M; Rauschecker, H; dos Santos, J G; Stremmel, W; Roelofsen, F.

Eur J Cancer ; 33(8): 1209-15, 1997 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-9301444

14.

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group.

Wils, J; Blijham, G H; Wagener, Th; De Greve, J; Jansen, R L H; Kok, T C; Nortier, J W R; Bleiberg, H; Couvreur, M L; Genicot, B; Baron, B.

Eur J Cancer ; 39(3): 346-52, 2003 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-12565987

15.

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).

Van Cutsem, E; Cunningham, D; Ten Bokkel Huinink, W W; Punt, C J; Alexopoulos, C G; Dirix, L; Symann, M; Blijham, G H; Cholet, P; Fillet, G; Van Groeningen, C; Vannetzel, J M; Levi, F; Panagos, G; Unger, C; Wils, J; Cote, C; Blanc, C; Hérait, P; Bleiberg, H.

Eur J Cancer ; 35(1): 54-9, 1999 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-10211088

16.

The treatment of advanced gastric cancer.

Wils, J.

Semin Oncol ; 23(3): 397-406, 1996 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-8658224

17.

High-dose fluorouracil: a new perspective in the treatment of colorectal cancer?

Wils, J A.

Semin Oncol ; 19(2 Suppl 3): 126-30, 1992 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-1557637

18.

[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]. / Association de 5-FU, méthotrexate à haute dose, épirubicine et cisplatine (FEMTX-P) dans les cancers gastriques métastatiques, inopérables ou en récidive locale.

Conroy, T; Wils, J; Paillot, B; Wagener, D J; Burghouts, J T; Fickers, M M; de Graeff, A; Lalisang, F M.

Bull Cancer ; 80(3): 255-60, 1993 Mar.

Artículo en Francés | MEDLINE | ID: mdl-8173178

19.

Adjuvant treatment of colon cancer. A plea for a large-scale European trial.

Wils, J; Bleiberg, H; Rougier, P.

Eur J Cancer ; 30A(5): 578-9; discussion 579-80, 1994.

Artículo en Inglés | MEDLINE | ID: mdl-8080668

20.

Adjuvant treatment of colorectal cancer in The Netherlands: a commentary.

Wils, J.

Neth J Med ; 49(1): 52-5, 1996 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-8772361

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Adjuvant treatment of colon cancer: past, present and future.

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study.

Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.

Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.

Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group.

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.

Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and well-tolerated regimen for the treatment of advanced breast cancer.

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group.

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).

The treatment of advanced gastric cancer.

High-dose fluorouracil: a new perspective in the treatment of colorectal cancer?

Adjuvant treatment of colon cancer. A plea for a large-scale European trial.

Adjuvant treatment of colorectal cancer in The Netherlands: a commentary.